Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1539 | 2.150 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 1026 | 1.980 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 982 | 1.610 |
Why?
|
| Gait | 6 | 2021 | 407 | 1.280 |
Why?
|
| Hippocampus | 6 | 2020 | 262 | 1.200 |
Why?
|
| Exercise | 6 | 2021 | 399 | 1.060 |
Why?
|
| Cognition | 10 | 2022 | 1237 | 1.040 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 2020 | 0.940 |
Why?
|
| Aged, 80 and over | 28 | 2022 | 4509 | 0.930 |
Why?
|
| Aging | 8 | 2021 | 1460 | 0.900 |
Why?
|
| Postural Balance | 3 | 2021 | 112 | 0.850 |
Why?
|
| Postmortem Changes | 2 | 2016 | 31 | 0.810 |
Why?
|
| Independent Living | 5 | 2021 | 280 | 0.810 |
Why?
|
| Neuropathology | 3 | 2021 | 79 | 0.810 |
Why?
|
| Male | 35 | 2022 | 13669 | 0.680 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 44 | 0.680 |
Why?
|
| Female | 35 | 2022 | 14048 | 0.670 |
Why?
|
| White Matter | 5 | 2018 | 131 | 0.670 |
Why?
|
| Humans | 47 | 2022 | 24703 | 0.630 |
Why?
|
| Aged | 25 | 2022 | 8382 | 0.580 |
Why?
|
| Autopsy | 9 | 2021 | 329 | 0.580 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 57 | 0.580 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 52 | 0.560 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 111 | 0.530 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 708 | 0.490 |
Why?
|
| Motor Activity | 1 | 2018 | 308 | 0.480 |
Why?
|
| Thalamus | 3 | 2021 | 15 | 0.450 |
Why?
|
| Atrophy | 3 | 2021 | 81 | 0.450 |
Why?
|
| Knee Joint | 1 | 2019 | 744 | 0.410 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 205 | 0.390 |
Why?
|
| Accelerometry | 4 | 2021 | 87 | 0.370 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 63 | 0.370 |
Why?
|
| Walking | 4 | 2022 | 244 | 0.360 |
Why?
|
| Neuroimaging | 3 | 2021 | 118 | 0.350 |
Why?
|
| Walking Speed | 2 | 2021 | 36 | 0.330 |
Why?
|
| Gray Matter | 3 | 2021 | 50 | 0.320 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1293 | 0.320 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 199 | 0.320 |
Why?
|
| Formaldehyde | 1 | 2009 | 6 | 0.310 |
Why?
|
| RNA, Messenger | 2 | 2022 | 294 | 0.310 |
Why?
|
| Temporal Lobe | 2 | 2020 | 86 | 0.290 |
Why?
|
| Cohort Studies | 8 | 2020 | 1748 | 0.290 |
Why?
|
| Brain Mapping | 3 | 2017 | 145 | 0.280 |
Why?
|
| Parkinson Disease | 4 | 2021 | 633 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 192 | 0.280 |
Why?
|
| Dementia | 2 | 2022 | 519 | 0.250 |
Why?
|
| Organ Size | 3 | 2015 | 93 | 0.230 |
Why?
|
| Nerve Net | 2 | 2021 | 38 | 0.210 |
Why?
|
| Sclerosis | 3 | 2019 | 66 | 0.210 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 1135 | 0.200 |
Why?
|
| Transcriptome | 2 | 2022 | 82 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 85 | 0.200 |
Why?
|
| DNA Methylation | 3 | 2019 | 154 | 0.190 |
Why?
|
| Tremor | 2 | 2021 | 101 | 0.190 |
Why?
|
| Proteome | 1 | 2022 | 35 | 0.180 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 8 | 0.180 |
Why?
|
| Proteomics | 1 | 2022 | 84 | 0.180 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 8 | 0.180 |
Why?
|
| Motor Skills | 1 | 2021 | 45 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 124 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 103 | 0.170 |
Why?
|
| Neuropeptides | 2 | 2019 | 26 | 0.170 |
Why?
|
| Frailty | 1 | 2021 | 28 | 0.170 |
Why?
|
| Hand Strength | 1 | 2021 | 53 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2021 | 29 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 196 | 0.170 |
Why?
|
| Cognitive Aging | 1 | 2021 | 77 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2017 | 943 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 122 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2020 | 60 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 146 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 96 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 17 | 0.160 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 12 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2021 | 107 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 25 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 132 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 81 | 0.150 |
Why?
|
| Memory | 3 | 2017 | 281 | 0.150 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 11 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 38 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 82 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2019 | 123 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 12 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 252 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 75 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 37 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 234 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Femur | 1 | 2020 | 369 | 0.130 |
Why?
|
| Plasmacytoma | 1 | 2016 | 7 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 11 | 0.130 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 30 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 84 | 0.130 |
Why?
|
| Neurons | 1 | 2019 | 326 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 151 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 159 | 0.120 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 57 | 0.120 |
Why?
|
| Neocortex | 1 | 2016 | 30 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 41 | 0.120 |
Why?
|
| Algorithms | 2 | 2019 | 330 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 303 | 0.120 |
Why?
|
| Adult | 8 | 2021 | 7255 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 1847 | 0.120 |
Why?
|
| Joint Instability | 1 | 2019 | 394 | 0.110 |
Why?
|
| Locomotion | 1 | 2014 | 24 | 0.110 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 362 | 0.100 |
Why?
|
| Middle Aged | 6 | 2021 | 8294 | 0.100 |
Why?
|
| Shoulder Joint | 1 | 2019 | 654 | 0.100 |
Why?
|
| Memory, Episodic | 1 | 2011 | 110 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 37 | 0.090 |
Why?
|
| Mortality | 2 | 2021 | 84 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 2099 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 6 | 0.080 |
Why?
|
| Sex Factors | 2 | 2021 | 443 | 0.080 |
Why?
|
| Chicago | 2 | 2021 | 858 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 177 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 254 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 156 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 613 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 598 | 0.050 |
Why?
|
| Depression | 2 | 2017 | 390 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 14 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 32 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 72 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 102 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2021 | 22 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2021 | 45 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 199 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 110 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 12 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 91 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 10 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 8 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 18 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 14 | 0.040 |
Why?
|
| Software | 1 | 2019 | 55 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 174 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 51 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 807 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2019 | 492 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 9 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 115 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 13 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 38 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 814 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 728 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 37 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 632 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 697 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 240 | 0.030 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 144 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 5 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 33 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 39 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 674 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 61 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 197 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 78 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 571 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 253 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 131 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 262 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 332 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1671 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1612 | 0.030 |
Why?
|
| United States | 1 | 2021 | 1873 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 98 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 128 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 20 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 21 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 284 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 44 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 150 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 254 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 437 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 372 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 1992 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3156 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 611 | 0.020 |
Why?
|